Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoloft and Ara-C in Relapsed/Refractory AML
NCT02891278Phase 1Completed
- Sponsor
- Columbia University
- Start
- Aug 2016
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
Phase 1, open-label trial of sertraline in acute myeloid leukemia (AML), sponsored by Columbia University. Started Aug 2016; status: completed.
02
Drugs
sertraline
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02891278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02891278.